Mark Levy, FRCGP: Digital Inhaler Increases Treatment Adherence

Video

In a new study presented at ERS 2020, Dr. Mark Levy discusses how a digital inhaler reduces the amount of people who use their inhaler incorrectly.

Inhaler use can be difficult for some asthma patients, leading to faulty adherence and improper dosing of medications.

However, with the advent of new technology, it might soon be easier to know when an inhaler is being improperly used so that the problems can ultimately be corrected.

In a poster presented at the European Respiratory Society International Congress 2020 (ERS 2020), researchers presented data testing a new digital inhaler that alerts the user through a smartphone application whether or not they are using the inhaler correctly.

By promoting better inhaler techniques, the researchers believe ultimately they can severely reduce the amount of preventable asthma hospitalizations and improve care for the disease.

In the 696 patient study, the investigators found the digital inhaler helped identify patterns of use and provided clinically meaningful information early and facilitated physician-patient interventions and conversations.

In an interview with HCPLive®, Mark L. Levy, FRCGP, discusses why patients seem to struggle with inhalers and how digitalizing the technology could have a drastic impact on reducing asthma hospitalizations.

Levy explained how inhaler technique has long been an issue for asthma patients and that many of the asthma issues ultimately could have been prevented.

Recent Videos
Arshad Khanani, MD: Four-Year Outcomes of Faricimab for DME in RHONE-X | Image Credit: Sierra Eye Associates
Dilraj Grewal, MD: Development of MNV in Eyes with Geographic Atrophy in GATHER | Image Credit: Duke Eye Center
Margaret Chang, MD: Two-Year Outcomes of the PDS for Diabetic Retinopathy | Image Credit: Retina Consultants Medical Group
Carl C. Awh, MD: | Image Credit:
Raj K. Maturi, MD: 4D-150 for nAMD in PRISM Population Extension Cohort | Image Credit: Retina Partners Midwest
Charles C. Wykoff, MD, PhD: Interim Analysis on Ixo-Vec Gene Therapy for nAMD | Image Credit: Retina Consultants of Texas
Sunir J. Garg, MD: Pegcetacoplan Preserves Visual Function on Microperimetry | Image Credit: Wills Eye Hospital
Edward H. Wood, MD: Pharmacodynamics of Subretinal RGX-314 for Wet AMD | Image Credit: Austin Retina Associates
Dilsher Dhoot, MD: OTX-TKI for NPDR in Interim Phase 1 HELIOS Results  | Image Credit: LinkedIn
Katherine Talcott, MD: Baseline EZ Integrity Features Predict GA Progression | Image Credit: LinkedIn
© 2024 MJH Life Sciences

All rights reserved.